SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-022190
Filing Date
2021-02-12
Accepted
2021-02-12 18:02:26
Documents
1
Period of Report
2021-02-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm214979-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm214979-8_4seq1.xml 4 4198
  Complete submission text file 0001104659-21-022190.txt   5664
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VALLON PHARMACEUTICALS, INC. 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address
Ammer Richard (Reporting) CIK: 0001843671 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 21630480